Intracellular Lipid Accumulation in Liver and Muscle and the Insulin Resistance Syndrome

Endocrinology and Metabolism Clinics of North America

Volumn 37, Issue 4, 2008, Pages 841-856

  Lara Castro, Cristina ^a   Garvey, W Timothy ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Hepatic steatosis; Inflammation; Insulin resistance; Intramyocellular fat; Muscle fat

Indexed keywords

FAT DROPLET; LIPID; PERILIPIN;

ADIPOSE TISSUE; BODY FAT DISTRIBUTION; DIET; DISEASE ASSOCIATION; EXERCISE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; LIVER CELL; METABOLIC SYNDROME X; MUSCLE CELL; MUSCLE TISSUE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RACE DIFFERENCE; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; WEIGHT REDUCTION;

ANIMALS; BODY FAT DISTRIBUTION; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS, TYPE 2; HUMANS; INTRACELLULAR SPACE; LIPID METABOLISM; LIVER; METABOLIC SYNDROME X; MUSCLES; OBESITY;

EID: 56249108377     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2008.09.002     Document Type: Review

References (91)

1. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndromes. Circulation 112 (2005) 735-752
2. Reaven G.M. Pathophysiology of insulin resistance in human disease. Physiol Rev 75 (1995) 473-486
3. Liao Y., Kwon S., Shaughnessy S., et al. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care 27 4 (2004) 978-983
4. Festa A., D'Agostino Jr. R., Howard G., et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 1 (2000) 42-47
5. Lara-Castro C., Luo N., Wallace P., et al. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55 (2006) 249-259
6. Grundy S.M. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 92 (2007) 399-404
7. Lara-Castro C., and Garvey W.T. Diet, insulin resistance, and obesity: zoning in on data for Atkins dieters living in South Beach. J Clin Endocrinol Metab 89 (2004) 4197-4205
8. Paradisi G., Smith L., Burtner C., et al. Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care 22 (1999) 1310-1317
9. Groop L.C., Saloranta C., Shank M., et al. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 72 (1991) 96-107
10. Kelley D.E. Skeletal muscle fat oxidation: timing and flexibility are everything. J Clin Invest 115 (2005) 1699-1702
11. Savage D.B., Petersen K.F., and Shulman G.I. Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension 45 (2005) 828-833
12. Yki-Jarvinen H., Puhakainen I., Saloranta C., et al. Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources. Am J Physiol 260 (1991) E680-E689
13. Carlson L.A., Ekelund L.G., and Froberg S.O. Concentration of triglycerides, phospholipids, and glycogen in skeletal muscle and of free fatty acids and beta-hydroxybutyric acid in blood in man in response to exercise. Eur J Clin Invest 1 (1971) 248-254
14. Pan D.A., Lillioja S., Kriketos A.D., et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46 (1997) 983-988
15. Colberg S.R., Simoneau J.A., Thaete F.L., et al. Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin Invest 95 (1994) 1846-1853
16. Simoneau J.-A., Colberg S.R., Thaete F.L., et al. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J 9 (1995) 273-278
17. Kelley D.E., and Simoneau J.-A. Impaired free fatty acid utilization by skeletal muscle in noninsulin-dependent diabetes mellitus. J Clin Invest 94 (1994) 2349-2356
18. Falholt K., Jenson I., Lindkaer-Jensen S., et al. Carbohydrate and lipid metabolism of skeletal muscle in type 2 diabetic patients. Diabet Med 1 (1988) 27-31
19. Froberg S.O. Muscle triglycerides: relation to glycogen in muscle and plasma triglycerides in men of different ages. Acta Med Scand 193 (1973) 463-468
20. Froberg S.O. Concentration of cholesterol and triglycerides in skeletal muscle of healthy men and myocardial infarction patients. Acta Med Scand 194 (1973) 553-558
21. Schick F., Eismann B., Jung W.I., et al. Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue. Magn Reson Med 29 (1993) 158-167
22. Rico-Sanz J., Hajnal J.V., Thomas E.L., et al. Intracellular and extracellular skeletal muscle triglyceride metabolism during alternating intensity exercise in humans. J Physiol 510 (1998) 615-622
23. Jacob S., Machaan J., Rett K., et al. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48 (1999) 1113-1119
24. Goodpaster B.H., Thaete F.L., Simoneau J.A., et al. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 46 (1997) 1579-1585
25. Storlien L.H., Oakes N.D., Pan D.A., et al. Syndromes of insulin resistance in the rat: inducement by diet and amelioration with benfluorex. Diabetes 42 (1993) 457-462
26. Chen M.-T., Kaufman L.N., Spennetta T., et al. Effects of high-rat feeding to rats on the interrelationship of body weight, plasma insulin, and fatty acyl-coenzyme A esters in liver and skeletal muscle. Metabolism 41 (1992) 564-569
27. Shillabeer G., Chamoun C., Hatch G., et al. Exogenous triacylglyercol inhibits insulin-stimulated glucose transport in L6 muscle cells in vitro. Biochem Biophys Res Commun 207 (1995) 768-774
28. y mouse: effects of pioglitazone on malyonyl-CoA and diacylglycerol. Am J Physiol 267 (1994) E95-E101
29. Schrauwen-Hinderling V.B., Schrauwen P., Hesselink M.K., et al. The increase in intramyocellular lipid content is a very early response to training. J Clin Endocrinol Metab 88 (2003) 1610-1616
30. Helge J., and Dela F. Effect of training on muscle triacylglycerol and structural lipids: a relationship to insulin sensitivity?. Diabetes 52 (2003) 1881-1887
31. Taylor C.R., Hoppeler H., Kennedy C., et al. High fat diet improves aerobic performance by building mitochondria. Physiologist 37 (1994) A84
32. He J., Goodpaster B.H., and Kelley D.E. Effects of weight loss and physical activity on muscle lipid content and droplet size. Obesity Res 12 (2004) 761-769
33. Boden G., Lebed B., Schatz M., et al. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50 (2001) 1612-1617
34. Bachmann O.P., Dahl D.B., Brechtel K., et al. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 50 (2001) 2579-2584
35. Greco A.V., Mingrone G., Giancaterini A., et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51 (2002) 144-151
36. Fabris R., Mingrone G., Milan G., et al. Further lowering of muscle lipid oxidative capacity in obese subjects after biliopancreatic diversion. J Clin Endocrinol Metab 89 (2004) 1753-1759
37. Goodpaster B.H., Theriault R., Watkins S.C., et al. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 49 (2000) 467-472
38. Lara-Castro C., Newcomer B.R., Rowell J., et al. Effects of short-term very low-calorie diet on intramyocellular lipid and insulin sensitivity in nondiabetic and type 2 diabetic subjects. Metabolism 57 (2008) 1-8
39. Kelley D.E., He J., Menshikova E.V., et al. Dysfunction in mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51 (2002) 2944-2950
40. Petersen K.F., Dufour S., Befroy D., et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350 (2004) 664-671
41. Petersen K.F., Befroy D., Dufour S., et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300 (2003) 1140-1142
42. Fromenty B., Robin M.A., Igoudjil A., et al. The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab 30 (2004) 121-138
43. Patti M.E., Butte A.J., Crunkhorn S., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 100 (2003) 8466-8471
44. Sreekumar R., Halvatsiotis P., Schimke J.C., et al. Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 51 (2002) 1913-1920
45. Yang X., Pratley R.E., Tokraks S., et al. Microarray profiling of skeletal muscle tissues from equally obese, non-diabetic insulin-sensitive and insulin-resistant Pima Indians. Diabetologia 45 (2002) 1584-1593
46. Wu X., Moellering D., Vestri H., et al. Dysregulation of mitochondria-related genes and transcription factors involved in mitochondrial biogenesis in skeletal muscle from insulin-resistant humans. Diabetes 54 Suppl 2 (2005) A273
47. Moellering D.R., Ulasova E., Landar A.L., et al. Proteomic analysis of skeletal muscle mitochondria in type 2 diabetes reveals altered concentrations and oxidation of respiratory chain proteins. Diabetes 54 Suppl 2 (2005) A58
48. Toledo F.G., Menshikova E.V., Azuma K., et al. Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content. Diabetes 57 4 (2008) 987-994
49. Ruhl C.E., and Everhart J.E. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 124 (2003) 71-79
50. Adams L.A., Lymp J.F., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129 (2005) 113-121
51. Park S.H., Kim B.I., Kim S.H., et al. Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men. J Am Coll Nutr 26 (2007) 321-326
52. Deivanayagam S., Mohammed B.S., Vitola B.E., et al. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents. Am J Clin Nutr 88 (2008) 257-262
53. Musso C., Cochran E., Moran S.A., et al. Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective. Medicine 83 (2004) 209-222
54. Cochran E., Young J.R., Sebring N., et al. Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome. J Clin Endocrinol Metab 89 (2004) 1548-1554
55. Maeda N., Shimomura I., Kishida K., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8 (2002) 731-737
56. Yano W., Kubota N., Itoh S., et al. Molecular mechanism of moderate insulin resistance in adiponectin-knockout mice. Endocr J 55 (2008) 515-522
57. Weisberg S.P., McCann D., Desai M., et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 (2003) 1796-1808
58. Bruun J.M., Helge J.W., Richelsen B., et al. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab 90 (2006) E961-E967
59. Unger R.H. Lipotoxic diseases. Annu Rev Med 53 (2002) 319-336
60. Ebihara K., Kusakabe T., Hirata M., et al. Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy. J Clin Endocrinol Metab 92 (2007) 532-541
61. Bajaj M., Suraamornkul S., Pratipanawatr T., et al. Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes. Diabetes 52 (2003) 1364-1370
62. Tontonoz P., Hu E., and Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79 (1994) 1147-1156
63. Crossno Jr. J.T., Majka S.M., Grazia T., et al. Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. J Clin Invest 116 (2006) 3220-3228
64. Iglesias P., Alvarez Fidalgo P., Codoceo R., et al. Lipoatrophic diabetes in an elderly woman: clinical course and serum adipocytokine concentrations. Endocr J 51 (2004) 279-286
65. Sevastianova K., Sutinen J., Kannisto K., et al. Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy. Am J Physiol Endocrinol Metab 295 (2008) E85-E91
66. Sopasakis V.R., Sandqvist M., Gustafson B., et al. High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes Res 12 (2004) 454-460
67. Gustafson B., and Smith U. Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. J Biol Chem 281 (2006) 9507-9516
68. Fu Y., Luo N., Klein R.L., et al. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res 46 (2005) 1369-1379
69. Makkonen J., Westerbacka J., Kolak M., et al. Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity. Int J Obes 31 (2007) 1617-1625
70. Kolak M., Westerbacka J., Velagapudi V.R., et al. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 56 (2007) 1960-1968
71. Bell M., Wang H., Chen H., et al. Consequences of lipid droplet coat protein downregulation in liver cells: abnormal lipid droplet metabolism and induction of insulin resistance. Diabetes 57 (2008) 2037-2045
72. Tansey J.T., Sztalryd C., Gruia-Gray J., et al. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A 98 (2001) 6494-6499
73. Martinez-Botas J., Anderson J.B., Tessier D., et al. Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat Genet 26 (2000) 474-479
74. Reue K., and Zhang P. The lipin protein family: dual roles in lipid biosynthesis and gene expression. FEBS Lett 582 (2008) 90-96
75. Peterfy M., Phan J., Xu P., et al. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat Genet 27 (2001) 121-124
76. Suviolahti E., Reue K., Cantor R.M., et al. Cross-species analyses implicate Lipin 1 involvement in human glucose metabolism. Hum Mol Genet 15 (2006) 377-386
77. Yao-Borengasser A., Rasouli N., Varma V., et al. Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor gamma activation. Diabetes 55 (2006) 2811-2818
78. Wild S., Roglic G., Green A., et al. Global prevalence of diabetes-estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1055
79. Brancati F.L., Kao W.H.L., Folsom A.R., et al. Incident type 2 diabetes mellitus in African American and white adults-the atherosclerosis risk in communities study. JAMA 2253 (2000) 2259
80. Harris M.I. Noninsulin-dependent diabetes mellitus in black and white Americans. Diabetes Metab Rev 6 (1990) 71-90
81. Lovejoy J.C., de la Bretonne J.A., Klemperer M., et al. Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism 45 (1996) 1119-1124
82. Lara-Castro C., Weinsier R.L., Hunter G.R., et al. Visceral adipose tissue in women: longitudinal study of the effects of fat gain, time, and race. Obes Res 10 (2002) 868-874
83. Weinsier R.L., Hunter G.R., Gower B.A., et al. Body fat distribution in white and black women: different patterns of intraabdominal and subcutaneous abdominal adipose tissue utilization with weight loss. Am J Clin Nutr 74 (2001) 631-636
84. Gower B.A., Nagy T.R., and Goran M.I. Visceral fat, insulin sensitivity, and lipids in prepubertal children. Diabetes 48 (1999) 1515-1521
85. van der Merwe M.T., Crowther N.J., Schlaphoff G.P., et al. Evidence for insulin resistance in black women from South Africa. Int J Obes Relat Metab Disord 24 (2000) 1340-1346
86. Stein E., Kushner H., Gidding S., et al. Plasma lipid concentrations in nondiabetic African American adults: associations with insulin resistance and the metabolic syndrome. Metabolism 56 (2007) 954-960
87. Gower B.A., Fernandez J.R., Beasley T.M., et al. Using genetic admixture to explain racial differences in insulin-related phenotypes. Diabetes 52 (2003) 1047-1051
88. Heimburger K., Lara-Castro C., Newcomer B., et al. Racial differences in intramyocellular lipids and its relationship to metabolic tirals. Obesity 15 Suppl 1 (2007) A206
89. Giday S.A., Ashiny Z., Naab T., et al. Frequency of nonalcoholic fatty liver disease and degree of hepatic steatosis in African-American patients. J Natl Med Assoc 98 (2006) 1613-1615
90. Browning J.D., Kumar K.S., Saboorian M.H., et al. Ethnic differences in the prevalence of cryptogenic cirrhosis. Am J Gastroenterol 99 (2004) 292-298
91. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40 (2004) 1387-1395